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Abstract: A 38-year-old woman with diabetes mellitus complained of acute visual loss in the 
left eye (20/200) and swollen left upper eyelid. Slit lamp examination of the left eye revealed 
ciliary injection, posterior synechia iritis, numerous inflammatory cells, and fibrin exudates in 
the anterior chamber. T1-weighted enhanced magnetic resonance imaging demonstrated left 
lacrimal gland enhancement with inflammatory spread to the left anterior ocular segment. Blood 
examination showed increased blood sugar but the other components were within normal limits. 
The patient was treated with steroid pulse therapy (methylprednisolone 1 g/day × 3 days) under 
a blood sugar control regimen in consultation with an endocrinologist, after which additional 
peribulbar injection of triamcinolone acetonide (40 mg) was performed. Resolution of the 
anterior uveitis and the dacryoadenitis was obtained after 2 months and there was no recur-
rence 1 year after the therapy. This is a rare case of severe anterior uveitis caused by idiopathic 
dacryoadenitis in a patient with diabetes mellitus.
Keywords: anterior uveitis, idiopathic dacryoadenitis, diabetes mellitus, magnetic resonance 
imaging, steroid
Introduction
Anterior uveitis is an extremely rare complication of dacryoadenitis. Dacryoadenitis 
usually causes local symptoms such as swelling of the lacrimal gland and the upper 
eyelid, and temporal conjunctival injection.1 Only one case has been reported on 
anterior uveitis with mild inflammatory cells in the anterior chamber associated with 
lacrimal grand sarcoidosis.2
We report a case of severe anterior uveitis caused by idiopathic dacryoadenitis in 
a patient with diabetes mellitus.
Case report
A 38-year-old woman with diabetes mellitus complained of bilateral palpable lacri-
mal gland enlargement. She did not exhibit eyelid edema or tenderness at the time. 
Her visual acuity was 20/20 OU and intraocular pressure was 19 mmHg OU. Hertel 
exophthalmometry revealed 17 mm bilaterally. The ocular motility was normal and 
slit lamp examination did not demonstrate conjunctival injection, and inflammation 
in the anterior chamber and the vitreous cavity in both eyes.
Two weeks after the initial examination, the patient noticed acute visual loss and 
conjunctival injection in the left eye, and left eyelid swelling. Her left visual acuity 
declined to 20/200 OS, and left intraocular pressure increased to 28 mmHg. Hertel 
exophthalmometry indicated 20 mm OS, ie, 3 mm more proptotic than the   measurement Clinical Ophthalmology 2011:5 submit your manuscript | www.dovepress.com
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taken 2 weeks before. Movement of the left lateral rectus was 
restricted. Swelling and tenderness occurred in the left upper 
eyelid (Figure 1A). Slit lamp examination of the left eye dis-
closed ciliary injection, posterior synechia iritis, numerous 
inflammatory cells, and fibrin exudates in the anterior cham-
ber (Figure 1B), although no inflammatory sign was shown 
in the vitreous cavity. T1-weighted enhanced magnetic 
resonance imaging (MRI) illustrated enhancement of the 
left lacrimal gland and the anterior segment of the left globe 
(Figure 1C). The fasting blood sugar level was 201 mg/dL at 
the time, but blood tests for angiotensin-converting enzyme, 
rheumatoid factors, antinuclear antibodies, thyroid-related 
autoantibodies, antineutrophil cytoplasmic antibodies, anti-
Sjögren syndrome A and B antibodies, soluble interleukin-2 
receptor, and virus-associated immunoglobulins were all 
within normal limits or negative. The chest radiograph did 
not show hilar lymphadenopathies. The needle reaction was 
negative on physical examination. According to the find-
ings, we diagnosed it as an idiopathic orbital inflammatory 
syndrome (lacrimal type).3 In addition, we judged that the 
lacrimal gland inflammation caused the anterior uveitis.
After consulting an endocrinologist, we treated the patient 
immediately with steroid pulse therapy (methylprednisolone, 
1 g/day) for 3 successive days without oral steroids thereafter. 
Simultaneously, eye drops (dexamethasone, phenylephrine 
hydrochloride, and tropicamide) were administered 4 times a 
day. Fasting blood sugar was examined 3 times a day during 
the steroid pulse therapy. A hypoglycemic agent was admin-
istered, and insulin injection was transiently used for tem-
porary increase of blood sugar (when .250 mg/dL). Since 
slight eyelid swelling and uveitis remained 2 weeks after the 
second examination, triamcinolone acetonide (40 mg) was 
then injected into the left orbit via the supralateral part of 
the subtenon space. Two months after the second examina-
tion, her visual acuity improved to 20/20 OS with complete 
resolution of the anterior uveitis and dacryoadenitis,   without 
serious systemic side effects. Left intraocular pressure 
decreased to 19 mmHg during the treatment, and steroid-
induced glaucoma did not occur. There was no recurrence 
1 year after the therapy.
Discussion
The patient reported herein showed severe anterior uveitis 
caused by dacryoadenitis. This is an extremely rare entity, 
and only one sarcoidosis case with simultaneous anterior 
uveitis and dacryoadenitis has been reported so far.2 
  Sarcoidosis was excluded in our case on the results of the 
examinations, although biopsy was not performed. The severe 
anterior uveitis here was caused by the extension of simple 
dacryoadenitis without inflammatory disease background. 
Figure 1A Patient photograph. swollen left upper eyelid with redness.
Figure 1B slit lamp examination of the left eye. Ciliary injection, posterior synechia 
iritis, and fibrin tissues in the anterior chamber are shown.
Figure 1C T1-weighted enhanced magnetic resonance image. The spread of the 
lacrimal gland inflammation to the anterior segment of the left eye and the lateral 
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Anterior uveitis with dacryoadenitis
Idiopathic dacryoadenitis, therefore, should be considered 
as a possible cause of an anterior uveitis.
MRI is a useful tool for detecting dacryoadenitis, and 
contrast enhancement is more helpful for understanding 
inflammatory expansion. As our patient presented with 
palpable lacrimal gland enlargement, proptosis, and eyelid 
swelling in addition to the anterior uveitis, we took the MRI. 
When a patient shows findings other than simple uveitis, MRI 
with contrast enhancement is an essential examination for 
diagnosing the condition.
Our patient had diabetes mellitus, wherein vascular 
permeability increases.3 Diabetes mellitus causes vascular 
barrier damage, resulting in plasma leakage and fluid reten-
tion in surrounding tissues.4 Diabetes mellitus may have 
aggravated the inflammation, causing a larger inflammatory 
expansion.
We performed a short-term steroid pulse therapy, which 
is an effective procedure for treating both orbital inflamma-
tion and anterior uveitis.5,6 Although oral steroid therapy is 
occasionally used for such patients, it is often ineffective 
with long-term administration, causing many side effects.1 
  However, steroid pulse therapy may also induce vital side 
effects, such as a lethal level blood sugar, to patients with 
diabetes mellitus. Therefore, blood sugar in our patient was 
closely monitored and properly controlled by an endocrinolo-
gist during the treatment. We additionally performed a triam-
cinolone acetonide injection, which may have contributed to 
avoid serious systemic side effects with complete resolution 
of the uveitis and dacryoadenitis.7
In conclusion, our patient with diabetes mellitus showed 
severe anterior uveitis caused by idiopathic dacryoadenitis, 
the diagnosis of which was aided by MRI. The treatment was 
successfully performed by the steroid pulse and local injec-
tion therapies with assistance of an endocrinologist.
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